Search results
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 6 hours agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 3 hours agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 23 hours agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 7 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 21 hours agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via Yahoo News· 7 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
BioNTech SE Stock Price Today | BVMF B1NT34 Live Ticker - Investing.com
Investing.com· 2 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Explainer-What are the FLiRT COVID variants and are they more contagious?
KFGO· 5 hours agoBy Michael Erman NEW YORK (Reuters) - The so-called FLiRT variants of SARS-CoV-2 coronavirus that...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WHTC 1450 Holland· 7 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 7 days agoThe EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the...
